Information Provided By: 
Fly News Breaks for March 22, 2016
MASI, VIVO, BDX, CPHD, QDEL
Mar 22, 2016 | 05:52 EDT
Piper Jaffray analyst William Quirk says flu activity began to ramp in recent weeks with the CDC reporting the percent of influenza-like illnesses per outpatient visit during week 10 was 3.7%, above the 2.3% average. With the Street expecting little Q1 improvement in flu activity, Quidel (QDEL) could report upside to revenue expectations, Quirk tells investors in a research note. Cepheid (CPHD) could also benefit, and flu trends are also positive for Becton Dickinson (BDX), Meridian Bioscience (VIVO) and Masimo (MASI), the analyst contends.
News For QDEL;CPHD;BDX;VIVO;MASI From the Last 2 Days
There are no results for your query QDEL;CPHD;BDX;VIVO;MASI
